Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentostatin + cyclophosphamide + ofatumumab in older previously untreated chronic lymphocytic leukemia
2010-022332-37Phase 2Completed
- Sponsor
- ASST Grande Ospedale Metropolitano Niguarda
- Start
- Oct 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ofatumumab, pentostatin and cyclophosphamide in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), sponsored by ASST Grande Ospedale Metropolitano Niguarda. Primary endpoints: Complete response rate and Overall response rate. Started Oct 2010; status: completed.
02
Drugs
ofatumumabpentostatincyclophosphamide
03
Conditions
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on 2010-022332-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022332-37.